Answer
Abecma (idecabtagene vicleucel) is not recommended during pregnancy or for women of childbearing potential not using contraception because of potential foetal toxicity if transduced cells cross the placenta; pregnant women should be advised of potential foetal risks, and pregnancy after therapy should be discussed with the treating physician.
Sources for this answer
- Abecma 260 - 500 x 10^6 cells dispersion for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked